HEMOGENYX PHARMACEUTICALS PLC
HEMO | IL
Overview
Corporate Details
- ISIN(s):
- GB00BYX3WZ24
- LEI:
- 2138008L93GYU5GN6179
- Country:
- United Kingdom
- Address:
- 6TH FLOOR, 60 GRACECHURCH STREET, EC3V 0HR LONDON
- Website:
- https://hemogenyx.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Hemogenyx Pharmaceuticals PLC develops therapies for blood diseases and bone marrow transplantation.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for HEMOGENYX PHARMACEUTICALS PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-15 08:00 |
Regulatory News Service
Third Patient Treated with HG-CT-1 CAR-T Therapy
|
English | 12.2 KB | |
| 2025-07-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 10.1 KB | |
| 2025-07-29 09:00 |
Share Issue/Capital Change
Placing to Raise £250,000 and Director’s Dealing
|
English | 26.5 KB | |
| 2025-07-16 08:00 |
Regulatory News Service
Hemogenyx Awarded Grant
|
English | 14.6 KB | |
| 2025-06-30 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 9.6 KB | |
| 2025-06-03 15:02 |
Director's Dealing
Placing to Raise £451,250 and Director’s Dealing
|
English | 26.1 KB | |
| 2025-06-03 08:00 |
Legal Proceedings Report
Second Patient Passes Initial Safety Tests
|
English | 14.9 KB | |
| 2025-05-31 12:30 |
Post-Annual General Meeting Information
Resolutions passed at Annual General Meeting of Hemogenyx Pharmaceuticals plc o…
|
English | 33.9 KB | |
| 2025-05-29 15:06 |
Post-Annual General Meeting Information
Result of AGM
|
English | 27.1 KB | |
| 2025-05-20 21:50 |
Annual Report (ESEF)
Annual Report & Financial Statements for the Year Ended 31 December 2024
|
English | 673.1 KB | |
| 2025-05-20 21:50 |
Annual Report
Annual Report & Financial Statements for the Year Ended 31 December 2024
|
English | 2.4 MB | |
| 2025-05-14 08:00 |
Regulatory News Service
Pediatric Amendment to Clinical Protocol
|
English | 11.0 KB | |
| 2025-05-02 17:24 |
Pre-Annual General Meeting Information
Notice of AGM
|
English | 11.5 KB | |
| 2025-04-29 00:59 |
Annual Report
Annual Report & Financial Statements for the Year Ended 31 December 2024
|
English | 1.3 MB | |
| 2025-03-31 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 11.4 KB |
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for HEMOGENYX PHARMACEUTICALS PLC via our API.
Automate Your Workflow. Get a real-time feed of all HEMOGENYX PHARMACEUTICALS PLC filings delivered via API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |